Conferences / Meetings

Event Categories:

  • search by keywords:

Sponsored Links


  • FDA's Regulation of OTC Drug Products: 2-day In-Person

  • Hosted By:
  • ComplianceOnline
  • Start:
  • Thursday - Feb 13, 2014 08:30 AM
  • End Time:
  • Friday - Feb 14, 2014 04:30 PM
  • Location:
  • Houston,
    Texas, United States
  • Course Description:
    The U.S. Food and Drug Administration’s (“FDA”) is responsible for the regulation and oversight of the U.S. OTC drug market. Congress has granted FDA regulatory authority over the formulation, manufacturing, labeling, marketing and promotion; and import / export of OCT drug products into the U.S. Under this current regulatory regime, there are 3 pathways that a company may follow to enter the OTC drug market including (a) following an appropriate Drug Monograph; (b) with an Agency approved New Drug Application (“NDA”); or (c) via the currently popular Rx-to-OTC Switch Process.

    This course on FDA regulation of OTC drug products is intended to provide attendees with the knowledge and skills needed to develop and produce an OTC Drug Product for marketing and sale in the U.S. Attendees will gain an understanding of :

    -Various available options for producing and selling an OTC drug product,
    -U.S. Food and Drug Administration’s (“FDA”) regulation of OTC drug products,
    -Strategic recommendations for mitigating the risk of enforcement action in the future.

    Learning Objectives:
    Participants who attend this course on FDA regulation of OTC drugs will:

    -Gain a comprehensive understanding of how OTC Drug Products are regulated in the U.S.
    -Learn to distinguish between a potential Rx pharmaceutical product and an OTC drug.
    -Recognize the difference between the various pathways for commercializing an OTC Drug Product.
    -Understand how to identify and successfully navigate an OTC Drug Monograph.
    -Recognize when reliance on a Proposed Rule, Final Rule and/or Drug Monograph is appropriate.
    -Understand how to determine whether an Ingredient is considered Safe or GRAS/E for use in an OTC Drug and understand the difference between Category I, II and II Ingredient designations.
    -Identify the required elements of a compliant OTC Drug Label.
    -Take away strategies for marketing and promoting OTC drug products, and for mitigating potential enforcement risks.
    -Possess a working knowledge of the Rx-to-OTC Switch Process.
    -Review and evaluate several of FDA’s current OTC Monographs

    Who will Benefit:
    This course is designed for people tasked with formulation, manufacturing, labeling, marketing and promotion; and import / export of OCT drug products; and responsible for overseeing a company’s regulatory strategies. The following personnel will find this session valuable:

    -Senior quality managers
    -Quality professionals
    -Regulatory professionals
    -Compliance professionals
    -Production supervisors
    -Manufacturing engineers
    -Production engineers
    -Design engineers
    -Labelers and Private Labelers
    -Contract Manufacturers
    -Importers and Custom Agents
    -U.S. Agents of Foreign Corporations
    -Process owners
    -Quality engineers
    -Quality auditors
    -Document control specialists
    -Record retention specialists
    -Medical affairs
    -Legal Professionals
    -Financial Advisors and Institutional Investors
    -Consultants, Inspectors and cGMP Experts
  • Website:
  • Visit the website for detail info


No Comments available

© 2009-2020, All Rights Reserved.
Higher Ed Space ® is a registered trademark of AmeriCareers LLC.